Title
A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels
Author
Hanemaaijer, R.
Visser, H.
Konttinen, Y.T.
Koolwijk, P.
Verheijen, J.H.
Gaubius Instituut TNO
Publication year
1998
Abstract
Here we describe a new principle for accessing the activity of the different members of the human matrix-metalloproteinases (MMPs) by a colorimetric assay. Using protein engineering, a modified pro-urokinase was made in which the activation sequence, normally recognized by plasmin (ProArgPheLys ↓ IlelleGlyGly), was replaced by a sequence that is specifically recognized by MMPs (ArgProLeuGly ↓ IleIleGlyGly). The active urokinase resulting from the activation of this modified pro-urokinase by MMPs can be measured directly using a chromogenic peptide substrate for urokinase. The assay has been made specific for MMP-9 using an MMP-9 specific monoclonal antibody. Using this antibody MMP-9 is captured from biological fluids or tissue culture media, and MMP-activity of both active and latent MMP-9 can be analysed. We determined the gelatinase-B (MMP-9) activity present in saliva from patients with Sjögren's syndrome. Using a general gelatinase assay with radioactively-labeled gelatinated collagen it was observed that gelatinase activity was slightly, though not significantly, increased in patients: general gelatinase activity in patients versus healthy controls: 17.0 ± 4.9 vs 12.2 ± 2.5 x 104 cpm/ml (p > 0.05, and 44.0 ( 4.0 vs 36.1 ± 1.9 x 104 cpm/ml (p > 0.05), for active and latent gelatinase, respectively. However, using the immunocapture activity assay (using modified urokinase) specifically MMP-9 activity was measured, which was significantly increased in saliva from patients compared to healthy controls: MMP-9 (already active): patients 8.9 ± 2.5 U/mg, controls 1.0 ± 0.5 U/mg (p = 0.002); latent plus active MMP-9: patients 53.1 ± 9.8 U/mg, controls 16.5 ± 2.6 U/mg (p = 0.01). This assay, measuring MMP-9 activity using modified pro-urokinase as a substrate can easily be adapted for the specific detection of the various members of the MMP-family or other difficult to measure proteases, in a format that can be used for high throughput screening of compounds or samples.
Subject
Health
Activity assay
Gelatinase B
Matrix metalloproteinases (MMP)
Sjogren's syndrome
Urokinase
Animals
Antibodies, Monoclonal
Antibody Specificity
Collagenases
Female
Humans
Immunoassay
Matrix Metalloproteinase 9
Mice
Mice, Inbred BALB C
Saliva
Sensitivity and Specificity
Sjogren's Syndrome
Tissue Inhibitor of Metalloproteinase-2
Animalia
To reference this document use:
http://resolver.tudelft.nl/uuid:8e79ea03-e083-4395-8a10-5cf5237a486f
DOI
https://doi.org/10.1016/s0945-053x(98)90116-0
TNO identifier
234719
ISSN
0945-053X
Source
Matrix Biology, 17 (8-9), 657-665
Document type
article